TNFSF10 and glioblastoma: In a study by Bago et al. in 2016, the authors proved that the delivery of TNF-α-related apoptosis-inducing ligand (TRAIL) via iNSCs in murine GBM models resulted in a decreased growth of diffused and solid GBM xenografts by 20 and 230-fold respectively.